title: Nuclear extracts enhance the interaction of fusion proteins containing the DNA-binding domain of the androgen and glucocorticoid receptor with androgen and glucocorticoid response elements.
abstract: Comparable fragments of the androgen receptor (AR) (amino acids 540-607) and of the glucocorticoid receptor (GR) (amino acids 412-515) were expressed in E. coli as fusion proteins with protein A. Both fusion proteins, denoted ARF1 and GRF1, contain the DNA-binding domain and some flanking amino acids. In vitro binding assays have shown that both fusion proteins interact with androgen/glucocorticoid response elements (ARE/GREs) in an intron fragment of the C3(1) gene of the androgen-regulated rat prostatic binding protein and in the typically glucocorticoid-responsive long terminal repeat (LTR) promoter of mouse mammary tumour virus. Present results indicate that the interaction of both ARF1 and GRF1 with the C3(1) as well as the LTR fragments is enhanced in the presence of nuclear extract. The factor that gives rise to this enhancement appears to be ubiquitous and sensitive to trypsin and temperature treatment. In the C3(1) fragment, the enhancing effect requires the presence of an intact functional ARE/GRE (Core II) as well as a region spanning the ARE/GRE half-site Core I.
authors.affiliation: LEGENDO, Leuven, Belgium.
authors.forename: P
authors.initials: P
authors.lastname: De Vos
authors.forename: F
authors.initials: F
authors.lastname: Claessens
authors.forename: L
authors.initials: L
authors.lastname: Celis
authors.forename: B
authors.initials: B
authors.lastname: Peeters
authors.forename: W
authors.initials: W
authors.lastname: Rombauts
authors.forename: W
authors.initials: W
authors.lastname: Heyns
authors.forename: G
authors.initials: G
authors.lastname: Verhoeven
mesh_terms: D000728:Androgens / Q000494:pharmacology*; D000818:Animals; D001483:Base Sequence; D001665:Binding Sites; D002467:Cell Nucleus / Q000502:physiology*; D004247:DNA / Q000378:metabolism*; D005938:Glucocorticoids / Q000494:pharmacology*; D007438:Introns; D008297:Male; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D010446:Peptide Fragments / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D011401:Promoter Regions, Genetic; D011467:Prostate / Q000737:chemistry; D051381:Rats; D017208:Rats, Wistar; D011944:Receptors, Androgen / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D011965:Receptors, Glucocorticoid / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D011993:Recombinant Fusion Proteins / Q000378:metabolism*; D012091:Repetitive Sequences, Nucleic Acid; D013329:Structure-Activity Relationship; D013696:Temperature; D014357:Trypsin / Q000494:pharmacology
chemical_list: D000728:Androgens; D005938:Glucocorticoids; D010446:Peptide Fragments; D011944:Receptors, Androgen; D011965:Receptors, Glucocorticoid; D011993:Recombinant Fusion Proteins; D004247:DNA; D014357:Trypsin